BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu L, Wei J, Liu P. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol 2021:S1044-579X(21)00188-7. [PMID: 34175443 DOI: 10.1016/j.semcancer.2021.06.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Cai T, Bai J, Tan P, Huang Z, Liu C, Wu Z, Cheng Y, Li T, Chen Y, Ruan J, Gao L, Du Y, Fu W. Zyxin promotes hepatocellular carcinoma progression via activation the AKT/mTOR signaling pathway.. [DOI: 10.21203/rs.3.rs-2239977/v1] [Reference Citation Analysis]
2 Bouyahya A, El Allam A, Aboulaghras S, Bakrim S, El Menyiy N, Alshahrani MM, Al Awadh AA, Benali T, Lee L, El Omari N, Goh KW, Ming LC, Mubarak MS. Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy. Cancers 2022;14:5520. [DOI: 10.3390/cancers14225520] [Reference Citation Analysis]
3 Yang J, Liu Y, Lan S, Yu S, Ma X, Luo D, Shan H, Zhong X, Yan G, Li R. Discovery of 2-Methyl-2-(4-(2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-6-yl)-1H-naphtho[1,2-d]imidazol-1-yl)phenyl)propanenitrile as a Novel PI3K/mTOR Inhibitor with Enhanced Antitumor Efficacy In Vitro and In Vivo. J Med Chem 2022. [PMID: 36191148 DOI: 10.1021/acs.jmedchem.2c00572] [Reference Citation Analysis]
4 zeng X, Liu C, He Q, Zou Z, Liao Q, Wu C, Li G, Zhang Z, Tian Y, Zhu S, Yang X, Cui S, Zeng L. A novel lncRNA BF368575 promotes cell proliferation in hepatocellular carcinoma via PI3K/AKT/mTOR signaling pathway.. [DOI: 10.21203/rs.3.rs-2027515/v1] [Reference Citation Analysis]
5 Wei H, Zhou L, Zhao X, Xie F, Kaur A. Network-Based Pharmacological Study on the Mechanism of Action of Buxue Liqi Huatan Decoction in the Treatment of Lung Cancer. Computational Intelligence and Neuroscience 2022;2022:1-8. [DOI: 10.1155/2022/3418687] [Reference Citation Analysis]
6 Wang X, Zhang C, Ye M, Rokaya D. Study on the Mechanism of Xiaotan Sanjie Recipe in the Treatment of Colon Cancer Based on Network Pharmacology. BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/9498109] [Reference Citation Analysis]
7 Liu F, Liang Y, Sun R, Yang W, Liang Z, Gu J, Zhao F, Tang D. Astragalus mongholicus Bunge and Curcuma aromatica Salisb. inhibits liver metastasis of colon cancer by regulating EMT via the CXCL8/CXCR2 axis and PI3K/AKT/mTOR signaling pathway. Chin Med 2022;17:91. [PMID: 35922850 DOI: 10.1186/s13020-022-00641-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sajeev A, Hegde M, Daimary UD, Kumar A, Girisa S, Sethi G, Kunnumakkara AB. Modulation of diverse oncogenic signaling pathways by oroxylin A: An important strategy for both cancer prevention and treatment. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hussain Y, Khan H, Alam W, Aschner M, Abdullah, Alsharif KF, Saso L. Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy. Oxid Med Cell Longev 2022;2022:4831833. [PMID: 35795855 DOI: 10.1155/2022/4831833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wang Z, Wei Y, Zhu H, Yu L, Zhu J, Han Q, Liu Z, Huang J, Zhu Y, Fan G, Tang Q, Qian J, Chen X, Zhou G. LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p. BMC Cancer 2022;22:728. [PMID: 35787258 DOI: 10.1186/s12885-022-09833-5] [Reference Citation Analysis]
11 Dai Q, Ain Q, Rooney M, Song F, Zipprich A. Role of IQ Motif-Containing GTPase-Activating Proteins in Hepatocellular Carcinoma. Front Oncol 2022;12:920652. [DOI: 10.3389/fonc.2022.920652] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Abdelnaby RM, El-malah AA, Fakhreldeen RR, Saeed MM, Nadeem RI, Younis NS, Abdel-rahman HM, El-dydamony NM. In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers. Pharmaceuticals 2022;15:700. [DOI: 10.3390/ph15060700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhang X, Zheng X. Hsa_circ_0001495 contributes to cervical cancer progression by targeting miR-526b-3p/TMBIM6/mTOR axis. Reproductive Biology 2022;22:100648. [DOI: 10.1016/j.repbio.2022.100648] [Reference Citation Analysis]
14 Zhang T, Feng S, Li J, Wu Z, Deng Q, Yang W, Li J, Pan G. Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR/SHP pathway. Arch Toxicol 2022. [PMID: 35267068 DOI: 10.1007/s00204-022-03266-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zhang X, Liu Z, Chen S, Li H, Dong L, Fu X. A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway. J Ethnopharmacol 2022;283:114742. [PMID: 34655668 DOI: 10.1016/j.jep.2021.114742] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
16 Khanfar MA. Oxadiazol-based mTOR inhibitors with potent antiproliferative activities: synthetic and computational modeling. Mol Divers 2022. [PMID: 34985718 DOI: 10.1007/s11030-021-10367-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Jiang F, Lv Q, Hu C, Li Z, Wu H, Gao S, Wang H, Zhao Y, Shao Q. PCAT6 May Be a Whistler and Checkpoint Target for Precision Therapy in Human Cancers. Cancers (Basel) 2021;13:6101. [PMID: 34885209 DOI: 10.3390/cancers13236101] [Reference Citation Analysis]
18 Xue C, Li G, Lu J, Li L. Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression. Signal Transduct Target Ther 2021;6:400. [PMID: 34815385 DOI: 10.1038/s41392-021-00788-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
19 Mansour MA, Caputo VS, Aleem E. Highlights on selected growth factors and their receptors as promising anticancer drug targets. Int J Biochem Cell Biol 2021;140:106087. [PMID: 34563698 DOI: 10.1016/j.biocel.2021.106087] [Reference Citation Analysis]
20 Zhang Y, Zeng F, Zeng M, Han X, Cai L, Zhang J, Weng J, Gao Y. Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model. Int J Biol Sci 2021;17:3554-72. [PMID: 34512165 DOI: 10.7150/ijbs.62168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Wang PZ, Wei W. Special issue: Targeting cellular signaling pathways for cancer therapy. Semin Cancer Biol 2021:S1044-579X(21)00225-X. [PMID: 34487833 DOI: 10.1016/j.semcancer.2021.09.001] [Reference Citation Analysis]
22 Wu F, Chen Z, Liu J, Hou Y. The Akt-mTOR network at the interface of hematopoietic stem cell homeostasis. Exp Hematol 2021;103:15-23. [PMID: 34464661 DOI: 10.1016/j.exphem.2021.08.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]